These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7441964)

  • 1. [Antifibrillatory activity of propranolol in experimental myocardial infarct and its cardiodepressive and hypotensive action].
    Urbanics R; Shargorodskiĭ BM; Kovacs A; Raĭskina ME
    Kardiologiia; 1980 Oct; 20(10):78-81. PubMed ID: 7441964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of propranolol on the fibrillation threshold and the period of vulnerability of cardiac ventricles under normal conditions and during acute coronary occlusion].
    Mishchenko IK; Gal'tseva NA
    Kardiologiia; 1978 Apr; 18(4):79-84. PubMed ID: 671973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction.
    De Ferrari GM; Salvati P; Grossoni M; Ukmar G; Vaga L; Patrono C; Schwartz PJ
    J Am Coll Cardiol; 1993 Jul; 22(1):283-90. PubMed ID: 8509552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative characteristics of the experimental antifibrillatory action of anti-arrhythmia preparations].
    Storozhuk BG; Stoliarchuk AA
    Farmakol Toksikol; 1980; 43(5):579-81. PubMed ID: 7449988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The possible relationship between the antifibrillatory effect of inderal in experimental myocardial infarct and its effect on cardiac oxidation reduction processes and blood supply].
    Shargorodskii BM; Kats IA
    Kardiologiia; 1973 Mar; 13(3):81-7. PubMed ID: 4717189
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of the anti-arrhythmia effect of phosphocreatine in the acute stage of experimental myocardial infarction].
    Kryzhanovskiĭ SA; Vititnova MB; Kaverina NV; Bobkov IuG; Saks VA
    Kardiologiia; 1988 Nov; 28(11):100-3. PubMed ID: 3230761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of arrhythmia in myocardial infarct].
    Chazov EI
    Kardiologiia; 1968 Oct; 8(10):3-11. PubMed ID: 4179307
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental effects of anti-arrhythmic drugs on ventricular fibrillation thresholds altered by regional hyperkalemia.
    Logic JR
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):268-74. PubMed ID: 4748780
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of high doses of propranolol to reduce experimental myocardial ischemic damage.
    Peter T; Heng MK; Singh BN; Ambler P; Nisbet H; Elliot R; Norris RM
    Circulation; 1978 Mar; 57(3):534-40. PubMed ID: 624162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)].
    Schwartz PJ
    Cardiologia; 1996 Aug; 41(8):739-45. PubMed ID: 8925528
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-arrhythmia and antifibrillatory properties of dibenzazepine derivatives].
    Senova ZP; Lyskovtsev VV; Grigor'eva EK; Gorbunova VV; Kaverina NV
    Kardiologiia; 1986 Aug; 26(8):24-8. PubMed ID: 3761845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of lidocaine and pyromecaine on the size of an experimental myocardial infarct].
    Goldshteĭne GKh; Tsorin IB; Chichkanov GG
    Biull Eksp Biol Med; 1986 Feb; 101(2):177-9. PubMed ID: 3947734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic, antifibrillatory activities and reduction of infarct size after the calcium antagonist Ro 11-1781 (tiapamil) in anesthetized dogs.
    Saini RK; Antonaccio MJ
    J Pharmacol Exp Ther; 1982 Apr; 221(1):29-36. PubMed ID: 7062289
    [No Abstract]   [Full Text] [Related]  

  • 14. Ventricular fibrillation and myocardial necrosis after transient ischemia. Effect of treatment with oxygen, procainamide, reserpine, and propranolol.
    Sommers HM; Jennings RB
    Arch Intern Med; 1972 May; 129(5):780-9. PubMed ID: 5025900
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of propranolol on experimental periinfarction block and myocardial ischemia.
    Carp C
    Med Interne; 1977; 15(4):395-410. PubMed ID: 594624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The anti-arrhythmia activity of quinazopyrine].
    Stets VR; Beregovaia EG; Dunaev VV; Storozhuk BG; Favoritov VN; Stoliarchuk AA; Mazur AI
    Farmakol Toksikol; 1990; 53(3):15-7. PubMed ID: 2387373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion.
    Pearle DL; Williford D; Gillis RA
    Am J Cardiol; 1978 Dec; 42(6):960-4. PubMed ID: 727146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotensive and antiarrhythmic effects of a new alkaloid, the 13-hydroxylupanine-2-pyrrolcarbonic acid ester, from the Madagascan plant Cadia ellisiana.
    Lindner E; Kaiser J; Schacht U
    Arzneimittelforschung; 1976; 26(9):1651-7. PubMed ID: 11808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance and treatment of disorders of the cardiac rhythm in patients with myocardial infarct].
    Lukomskiĭ PE; Doshchitsin VL
    Kardiologiia; 1969 Jan; 9(1):3-16. PubMed ID: 4185135
    [No Abstract]   [Full Text] [Related]  

  • 20. Dibenzepin as an antifibrillatory agent for spontaneously terminating electrically induced ventricular fibrillation.
    Manoach M; Kauli N; Netz H; Beker B; Assael M
    Isr J Med Sci; 1979 May; 15(5):443-7. PubMed ID: 36362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.